A Former IVF Baby on "Three-Parent IVF"
By Jessica Cussins,
The Huffington Post
| 10. 24. 2013
I have my parents, and biotechnology, to thank for bringing me into this world; I was an IVF baby. Given this intimate connection with technology and test tubes, you might think I'd be a cheerleader for all developments in the field. But a new technique under consideration has broad and troubling implications, not only for hopeful parents-to-be and their potential future children, but for all of humanity.
This new technique, called mitochondrial replacement or "three-parent IVF," would make genetic changes to IVF embryos and thus to every cell of the children born as a result of it. And these changes would be passed down to future generations. Human inheritable genetic modification of this kind is currently prohibited in over 40 countries and by several international agreements due to numerous problems and concerns. But proposals that would break this long-respected international consensus are now under consideration in the United Kingdom and the United States.
The UK has been toying with the idea for some time and may soon change its law to allow clinical trials. Several US researchers also want...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...
